Actions Pathologists Can Take to Protect Their Income

By jpschlingman | From the Volume XXX, No. 12 – August 21, 2023 Issue

CEO SUMMARY: Pathology groups may feel their income is under attack from lower Medicare reimbursement rates and rising practice costs. But steps to protect that income can include carefully determin…

Read More

---

Competency Assessments Prove To Be a Nagging CLIA Deficiency

By Scott Wallask | From the Volume XXX, No. 11 – July 31, 2023 Issue

CEO SUMMARY: Competency assessment problems rank high among frequently cited deficiencies during CLIA inspections. Representatives from the CAP, COLA, and The Joint Commission explain what areas to…

Read More

---

CLIA Lab Accreditors Reveal Most Frequent Deficiencies

By Scott Wallask | From the Volume XXX, No. 8 – May 30, 2023 Issue

CEO SUMMARY: CAP, The Joint Commission, COLA, and A2LA took the stage at the recent Executive War College to detail their respective lists of the 10 most often-cited standards during…

Read More

---

Lab Execs Allegedly Lied to FDA about Faulty Tests

By Scott Wallask | From the Volume XXX, No. 7 – May 8, 2023 Issue

CEO SUMMARY: Three former executives of a lab testing company face criminal charges. Federal prosecutors claim that the three plaintiffs who previously worked at Magellan Diagnostics flagrantly hid…

Read More

---

Lab Accreditors CAP and Joint Commission Face Inspector Hiring Pressures

By Robert Michel | From the Volume XXX No. 3 – February 13, 2023 Issue

In an exclusive story, The Dark Report covers the difficulties facing lab accreditors the College of American Pathologists (CAP) and The Joint Commission (TJC) in staffing inspection and survey teams under CLIA. Like the clinical laboratories they accredit to the requirem…

Read More

---

CAP, Joint Commission Under Pressure to Add More Inspectors

By Scott Wallask | From the Volume XXX No. 3 – February 13, 2023 Issue

CEO SUMMARY: Like the clinical laboratories they accredit to the requirements of CLIA, The Joint Commission and College of American Pathologist (CAP) face recruitment and hiring pressures when it comes to their surveyors and inspectors. Labs involved with CAP’s peer inspections ma…

Read More

---

Joint Commission Will Not Accept COLA Accreditation

By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue

CEO SUMMARY: This may be a first in the 40-year history of CLIA accreditation of clinical laboratories. The Joint Commission (TJC) announced it will no longer recognize COLA’s laboratory accreditation program within “TJC-accredited facilities,” effective Jan 1, 2023. COLA-accredited labs …

Read More

---

January 23, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue

New data from the Association of American Medical Colleges (AAMC) offers further evidence of a decreasing talent pool of pathologists in the United States. Active physicians in anatomic and clinical pathology dropped from 13,201 in 2016 to 12,180 in 2021—a 7.7% decrease, according to the AAM…

Read More

---

Eight Macro Trends for Clinical Labs in 2023

By Robert Michel | From the Volume XXX, No. 1 – January 3, 2023 Issue

CEO SUMMARY: Laboratory administrators and pathologists will want to carefully study eight important trends that will guide their business strategies in 2023. Many of these macro trends center on financial and operational difficulties and ways to steer around these obstacles. Anothe…

Read More

---

January 3, 2023, Intelligence: Late-Breaking Lab News

By Scott Wallask | From the Volume XXX, No. 1 – January 3, 2023 Issue

At the moment, it appears that the controversial Verifying Accurate Leading-edge IVCT Development (VALID) Act will have a hard time passing in Congress. The bill, which is intended to shift regulation of laboratory-developed tests (LDTs) to the federal Food and Drug Administration…

Read More

---